Alina Diana Haşaş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alina Diana Haşaş has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Andrei Răzvan Codea
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3–5, 400372 Cluj-Napoca, Romania
4 shared publications - Bogdan Sevastre
Department of Pathophysiology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania
4 shared publications - Alexandra Biriș
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3–5, 400372 Cluj-Napoca, Romania
3 shared publications - Cristian Popovici
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3–5, 400372 Cluj-Napoca, Romania
3 shared publications - Dan Cristian Vodnar
Department of Food Science, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 400372 Cluj-Napoca, Romania
3 shared publications - Daniela Neagu
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3–5, 400372 Cluj-Napoca, Romania
3 shared publications
Latest Publications
- Open Access
Feasibility of a SOFA-Derived Organ Dysfunction Score in Cats with Systemic Inflammatory Response Syndrome
The Sequential Organ Failure Assessment (SOFA) score grades dysfunction in six components in people, using thresholds fixed against human reference ranges and a human case mix. Whether those numbers transfer to cats has not been examined. Of 52 cats assessed for eligibility, 23 met predefined systemic inflammatory response syndrome criteria, 22 of them non-septic, and an adapted score was calculated at admission from non-invasive measurements and one venous sample. A complete score was obtained in every cat. Under the applied bilirubin thresholds, the hepatic sub-score exceeded zero in 21 of 23 cats and, with the renal component, accounted for 63.0% of the mean total score; removing that component lowered the median total from 6.0 to 3.0 and left three cats scoring zero. Under stated physiological assumptions, translating the original PaO2/FiO2 thresholds through the feline oxyhaemoglobin dissociation curve placed the first respiratory threshold near 91%, rather than the 95% applied here, and removed the respiratory point from six cats. Five of the 23 cats did not survive to discharge, too few for any outcome analysis, and none was attempted. The framework was measurable in this setting, but its thresholds describe admission abnormalities rather than organ dysfunction and require feline-specific calibration.
Open AccessFeasibility of a SOFA-Derived Organ Dysfunction Score in Cats with Systemic Inflammatory Response Syndrome
The Sequential Organ Failure Assessment (SOFA) score grades dysfunction in six components in people, using thresholds fixed against human reference ranges and a human case mix. Whether those numbers transfer to cats has not been examined. Of 52 cats assessed for eligibility, 23 met predefined systemic inflammatory response syndrome criteria, 22 of them non-septic, and an adapted score was calculated at admission from non-invasive measurements and one venous sample. A complete score was obtained in every cat. Under the applied bilirubin thresholds, the hepatic sub-score exceeded zero in 21 of 23 cats and, with the renal component, accounted for 63.0% of the mean total score; removing that component lowered the median total from 6.0 to 3.0 and left three cats scoring zero. Under stated physiological assumptions, translating the original PaO2/FiO2 thresholds through the feline oxyhaemoglobin dissociation curve placed the first respiratory threshold near 91%, rather than the 95% applied here, and removed the respiratory point from six cats. Five of the 23 cats did not survive to discharge, too few for any outcome analysis, and none was attempted. The framework was measurable in this setting, but its thresholds describe admission abnormalities rather than organ dysfunction and require feline-specific calibration.
- Open Access
Comparative Metabolite Profiling of Betula pendula Roth and Betula pubescens Ehrh. Leaf Extracts Reveals Antioxidant and Hepatoprotective Potential
The present study compares the polyphenolic composition, as well as the antioxidant and hepatoprotective potential of extracts obtained from the leaves of Betula pendula Roth and Betula pubescens Ehrh. The extracts were prepared using 90% v/v ethanol and the phytochemical contents were assessed using spectrophotometric assays, while independent metabolites were identified and quantified using an LC/MS/ESI method. The antioxidant potential was evaluated by the DPPH radical and FRAP scavenging assays. Cytotoxicity was evaluated using human LX-2 hepatic stellate cells and HepG2 hepatocellular carcinoma cells. Cell viability assays were performed to determine the potential cytotoxic effects of the two extracts on cellular viability and overall metabolic activity. In vivo, hepatoprotective potential was assessed in a CCl4-induced model of hepatotoxicity. Results revealed the presence of flavonoids and polyphenolic compounds in the leaves of both species, with a more significant potential for the B. pendula leaf extracts. The cell viability assays showed that both extracts maintained high cell viability in LX-2 cells, whereas B. pubescens induced a more pronounced reduction in HepG2 cell viability than B. pendula under the tested experimental conditions. In vivo, CCl4 increased ALT activity to 193.0 ± 8.5 U/L, whereas B. pendula and B. pubescens at 200 mg/kg reduced ALT to 30.4 ± 6.6 and 117.4 ± 24.3 U/L, respectively. CCl4 also increased hepatic MDA levels from 202.7 ± 31.8 to 717.1 ± 31.6, which were reduced to 430.7 ± 100.5 and 448.7 ± 65.8 following treatment with B. pendula and B. pubescens at 200 mg/kg, respectively.
Open AccessComparative Metabolite Profiling of Betula pendula Roth and Betula pubescens Ehrh. Leaf Extracts Reveals Antioxidant and Hepatoprotective Potential
The present study compares the polyphenolic composition, as well as the antioxidant and hepatoprotective potential of extracts obtained from the leaves of Betula pendula Roth and Betula pubescens Ehrh. The extracts were prepared using 90% v/v ethanol and the phytochemical contents were assessed using spectrophotometric assays, while independent metabolites were identified and quantified using an LC/MS/ESI method. The antioxidant potential was evaluated by the DPPH radical and FRAP scavenging assays. Cytotoxicity was evaluated using human LX-2 hepatic stellate cells and HepG2 hepatocellular carcinoma cells. Cell viability assays were performed to determine the potential cytotoxic effects of the two extracts on cellular viability and overall metabolic activity. In vivo, hepatoprotective potential was assessed in a CCl4-induced model of hepatotoxicity. Results revealed the presence of flavonoids and polyphenolic compounds in the leaves of both species, with a more significant potential for the B. pendula leaf extracts. The cell viability assays showed that both extracts maintained high cell viability in LX-2 cells, whereas B. pubescens induced a more pronounced reduction in HepG2 cell viability than B. pendula under the tested experimental conditions. In vivo, CCl4 increased ALT activity to 193.0 ± 8.5 U/L, whereas B. pendula and B. pubescens at 200 mg/kg reduced ALT to 30.4 ± 6.6 and 117.4 ± 24.3 U/L, respectively. CCl4 also increased hepatic MDA levels from 202.7 ± 31.8 to 717.1 ± 31.6, which were reduced to 430.7 ± 100.5 and 448.7 ± 65.8 following treatment with B. pendula and B. pubescens at 200 mg/kg, respectively.
- Open Access
- 28 August 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (9) , 881
Serum Cystatin C and the Urinary NAG Index Identify an Altered Renal Biochemical Phenotype in Clinically Healthy Geriatric Dogs with Normal Serum Creatinine: A Three-Tier Cross-Sectional Study
Serum creatinine (sCr), blood urea nitrogen (BUN) and symmetric dimethylarginine (SDMA) reflect glomerular filtration only and are subject to non-renal confounders including lean body mass, limiting early detection of renal dysfunction in geriatric dogs. We evaluated serum cystatin C (sCysC) and the urinary N-acetyl-β-D-glucosaminidase-to-creatinine ratio (NAG index) as early renal markers in healthy geriatric dogs. Sixty-one neutered geriatric dogs, free of clinical disease and of extrarenal laboratory abnormalities, were stratified into three groups: controls (n = 36), subclinical (normal sCr, ≥1 elevated biomarker; n = 17) and azotaemic chronic kidney disease (CKD; sCr > 1.5 mg/dL; n = 8). sCysC was measured by a canine-specific ELISA and the NAG index by colorimetric assay. Of the 61 dogs, 17 (27.9%) had at least one elevated biomarker with normal sCr, and all 17 also had normal BUN, indicating pre-azotaemic changes identified predominantly by sCysC. The NAG index was elevated in 6/17 (35.3%) subclinical dogs and SDMA in none (0/17). Because sCysC status partly informed group allocation and no independent measure of glomerular filtration rate was obtained, these findings characterise an altered renal biochemical phenotype rather than establish diagnostic accuracy, and require prospective validation.
- 28 August 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (9) , 881
Open AccessSerum Cystatin C and the Urinary NAG Index Identify an Altered Renal Biochemical Phenotype in Clinically Healthy Geriatric Dogs with Normal Serum Creatinine: A Three-Tier Cross-Sectional Study
Serum creatinine (sCr), blood urea nitrogen (BUN) and symmetric dimethylarginine (SDMA) reflect glomerular filtration only and are subject to non-renal confounders including lean body mass, limiting early detection of renal dysfunction in geriatric dogs. We evaluated serum cystatin C (sCysC) and the urinary N-acetyl-β-D-glucosaminidase-to-creatinine ratio (NAG index) as early renal markers in healthy geriatric dogs. Sixty-one neutered geriatric dogs, free of clinical disease and of extrarenal laboratory abnormalities, were stratified into three groups: controls (n = 36), subclinical (normal sCr, ≥1 elevated biomarker; n = 17) and azotaemic chronic kidney disease (CKD; sCr > 1.5 mg/dL; n = 8). sCysC was measured by a canine-specific ELISA and the NAG index by colorimetric assay. Of the 61 dogs, 17 (27.9%) had at least one elevated biomarker with normal sCr, and all 17 also had normal BUN, indicating pre-azotaemic changes identified predominantly by sCysC. The NAG index was elevated in 6/17 (35.3%) subclinical dogs and SDMA in none (0/17). Because sCysC status partly informed group allocation and no independent measure of glomerular filtration rate was obtained, these findings characterise an altered renal biochemical phenotype rather than establish diagnostic accuracy, and require prospective validation.
- Open Access
- 18 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 706
Haematological Tracking of Thyroid Status During Methimazole Therapy and After Treatment Interruption in Hyperthyroid Cats: A Prospective Longitudinal Cohort Study
Background: Feline hyperthyroidism is the most prevalent endocrine disorder of older cats; TT4 monitoring is costly and often inaccessible. Methods: Forty-three cats with primary hyperthyroidism were followed prospectively at baseline (T0) and at 1, 3 and 6 months (T1, T2, T3). Hct, Hgb, MCV, ALT and TT4 were measured at each visit. Per-timepoint correlations, repeated-measures correlation (rmcorr), linear mixed-effects models, and Friedman and ROC analyses were performed. Results: TT4 correlated with Hct (r = 0.875 at T1 to 0.943 at T3), MCV (0.907 to 0.964), Hgb (0.836 to 0.946) and ALT (0.919 to 0.981), intensifying progressively. Within individual cats, Hct (rmcorr r = 0.873) and MCV (rmcorr r = 0.881) tracked TT4, and for Hct, the within-cat coefficient exceeded the between-cat coefficient. All primary parameters and ALT changed significantly from T0 to T1 (all p < 0.001). ROC analysis identified Hct ≥ 35.2% at T2 as the optimal cut-off (AUC = 0.972, 95% CI 0.914–1.000; sensitivity 96.7%, specificity 92.3%). Conclusions: Hct and MCV tracked TT4 within individual cats during methimazole therapy and returned toward pre-treatment values after discontinuation. A rising Hct or MCV in a treated cat may signal loss of therapeutic control and prompt TT4 re-evaluation, without replacing hormonal monitoring.
- 18 July 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (7) , 706
Open AccessHaematological Tracking of Thyroid Status During Methimazole Therapy and After Treatment Interruption in Hyperthyroid Cats: A Prospective Longitudinal Cohort Study
Background: Feline hyperthyroidism is the most prevalent endocrine disorder of older cats; TT4 monitoring is costly and often inaccessible. Methods: Forty-three cats with primary hyperthyroidism were followed prospectively at baseline (T0) and at 1, 3 and 6 months (T1, T2, T3). Hct, Hgb, MCV, ALT and TT4 were measured at each visit. Per-timepoint correlations, repeated-measures correlation (rmcorr), linear mixed-effects models, and Friedman and ROC analyses were performed. Results: TT4 correlated with Hct (r = 0.875 at T1 to 0.943 at T3), MCV (0.907 to 0.964), Hgb (0.836 to 0.946) and ALT (0.919 to 0.981), intensifying progressively. Within individual cats, Hct (rmcorr r = 0.873) and MCV (rmcorr r = 0.881) tracked TT4, and for Hct, the within-cat coefficient exceeded the between-cat coefficient. All primary parameters and ALT changed significantly from T0 to T1 (all p < 0.001). ROC analysis identified Hct ≥ 35.2% at T2 as the optimal cut-off (AUC = 0.972, 95% CI 0.914–1.000; sensitivity 96.7%, specificity 92.3%). Conclusions: Hct and MCV tracked TT4 within individual cats during methimazole therapy and returned toward pre-treatment values after discontinuation. A rising Hct or MCV in a treated cat may signal loss of therapeutic control and prompt TT4 re-evaluation, without replacing hormonal monitoring.
- Open Access
Therapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis
Background: Kinkeliba (Combretum micranthum G. Don), commonly used in West African traditional pharmacopeia for its anti-inflammatory and gastrointestinal properties, remains poorly studied regarding its potential role in the prevention or treatment of ulcerative colitis. Objective: This study evaluated the therapeutic potential of the ethanolic extract of Combretum micranthum (EECM) in a murine model of chronic DSS-induced colitis. Methods: Male C57BL/6 mice were subjected to three cycles of 1.5% DSS administration over nine weeks to induce chronic colitis. EECM was administered orally at 50, 100, or 200 mg/kg during the final week. Disease severity was evaluated using the Disease Activity Index (DAI), colon length, biochemical and hematological markers, along with histopathological and immunohistochemical assessment of colonic tissue. Results: EECM treatment significantly improved clinical parameters and prevented colon shortening in chronic DSS-induced colitis. These improvements were associated with the restoration of serum biochemical and hematological profiles, along with reduced histopathological damage and preservation of colonic tissue architecture. Immunohistochemical analysis further demonstrated decreased CD3-positive T-lymphocyte infiltration in colonic tissue, suggesting modulation of local immune cell responses. Conclusions: These findings highlight the therapeutic potential EECM in ulcerative colitis and support further investigations to elucidate its mechanisms of action and evaluate its efficacy in future translational studies.
Open AccessTherapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis
Background: Kinkeliba (Combretum micranthum G. Don), commonly used in West African traditional pharmacopeia for its anti-inflammatory and gastrointestinal properties, remains poorly studied regarding its potential role in the prevention or treatment of ulcerative colitis. Objective: This study evaluated the therapeutic potential of the ethanolic extract of Combretum micranthum (EECM) in a murine model of chronic DSS-induced colitis. Methods: Male C57BL/6 mice were subjected to three cycles of 1.5% DSS administration over nine weeks to induce chronic colitis. EECM was administered orally at 50, 100, or 200 mg/kg during the final week. Disease severity was evaluated using the Disease Activity Index (DAI), colon length, biochemical and hematological markers, along with histopathological and immunohistochemical assessment of colonic tissue. Results: EECM treatment significantly improved clinical parameters and prevented colon shortening in chronic DSS-induced colitis. These improvements were associated with the restoration of serum biochemical and hematological profiles, along with reduced histopathological damage and preservation of colonic tissue architecture. Immunohistochemical analysis further demonstrated decreased CD3-positive T-lymphocyte infiltration in colonic tissue, suggesting modulation of local immune cell responses. Conclusions: These findings highlight the therapeutic potential EECM in ulcerative colitis and support further investigations to elucidate its mechanisms of action and evaluate its efficacy in future translational studies.
- Open Access
In-Depth Characterization of Black Soldier Fly Larvae Reared on Phenolic-Rich Agro-Industrial Substrates
Black soldier fly (Hermetia illucens) larvae (BSFL) represent a sustainable protein source for animal feed, efficiently converting organic waste into high-value biomass. This study aimed to valorize agricultural by-products (apple, potato, and red beetroot peels) as rearing substrates to obtain larvae enriched with bioactive phenolic compounds, while evaluating their nutritional, functional, and safety characteristics. Larvae were reared on diets with varying inclusion levels of each peel’s by-products. Proximate analysis showed that the substrate type and inclusion level significantly (p < 0.05) influenced larval composition, with consistently high protein and variable ash and fat contents. Colorimetric measurements indicated that phenolic-rich diets, particularly apple by-products, promoted cuticle darkening, reflecting the impact of dietary phenols on pigmentation. Functional properties were also modulated by the substrates: 2% potato peel yielded the highest phenolic content, while 20% apple peel produced the highest flavonoid concentration, both enhancing antioxidant capacity across CUPRAC-Cupric Ion Reducing Antioxidant Capacity, ABTS-2,2′-azino-bis 3-ethylbenzothiazoline-6-sulfonic acid, and DPPH-1,1-diphenyl-2-picrylhydrazyl assays. Rheological analysis confirmed desirable non-Newtonian, shear-thinning behavior, suggesting improved technological quality. Mycotoxin testing revealed low Aflatoxin B1 but variable Zearalenone levels, highlighting the influence of substrate composition on toxin metabolism. Overall, agricultural by-products can produce enriched BSFL with enhanced nutritional and antioxidant properties, as long as the substrate choice and inclusion levels are carefully optimized for safety.
Open AccessIn-Depth Characterization of Black Soldier Fly Larvae Reared on Phenolic-Rich Agro-Industrial Substrates
Black soldier fly (Hermetia illucens) larvae (BSFL) represent a sustainable protein source for animal feed, efficiently converting organic waste into high-value biomass. This study aimed to valorize agricultural by-products (apple, potato, and red beetroot peels) as rearing substrates to obtain larvae enriched with bioactive phenolic compounds, while evaluating their nutritional, functional, and safety characteristics. Larvae were reared on diets with varying inclusion levels of each peel’s by-products. Proximate analysis showed that the substrate type and inclusion level significantly (p < 0.05) influenced larval composition, with consistently high protein and variable ash and fat contents. Colorimetric measurements indicated that phenolic-rich diets, particularly apple by-products, promoted cuticle darkening, reflecting the impact of dietary phenols on pigmentation. Functional properties were also modulated by the substrates: 2% potato peel yielded the highest phenolic content, while 20% apple peel produced the highest flavonoid concentration, both enhancing antioxidant capacity across CUPRAC-Cupric Ion Reducing Antioxidant Capacity, ABTS-2,2′-azino-bis 3-ethylbenzothiazoline-6-sulfonic acid, and DPPH-1,1-diphenyl-2-picrylhydrazyl assays. Rheological analysis confirmed desirable non-Newtonian, shear-thinning behavior, suggesting improved technological quality. Mycotoxin testing revealed low Aflatoxin B1 but variable Zearalenone levels, highlighting the influence of substrate composition on toxin metabolism. Overall, agricultural by-products can produce enriched BSFL with enhanced nutritional and antioxidant properties, as long as the substrate choice and inclusion levels are carefully optimized for safety.
- Open Access
- 22 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11299
Ethanolic Extract of Kinkeliba (Combretum micranthum), Rich in Phenolic Compounds Mitigates DSS-Induced Ulcerative Colitis in C57BL/6 Mice via Antioxidation and Microbiota Regulation
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract, and current therapies are limited by adverse side effects. Combretum micranthum G. Don (kinkeliba), a medicinal plant traditionally used in West Africa, has been reported to possess pharmacological activities and a favorable safety profile. In this study, an ethanolic extract of Combretum micranthum (EECM) was characterized using HPLC-DAD-ESI-MS to identify its phenolic constituents. Acute colitis was induced in C57BL/6 mice using 3% DSS, while EECM (100 and 200 mg/kg) was administered orally for seven days. Disease Activity Index was monitored daily, and colonic injuries were evaluated through macroscopic and histological analyses, as well as hematological and biochemical assessments. In vitro, EECM contained 293.54 mg/g of total phenolic compounds and showed strong antioxidant activity in DPPH, ABTS, and FRAP assays. Furthermore, the extract exhibited antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Salmonella enterica, and Streptococcus pyogenes at various concentrations. In contrast, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa were not affected at the tested concentrations. No antifungal activity was detected against the filamentous fungus Aspergillus brasiliensis and the yeasts Saccharomyces cerevisiae, Candida parapsilosis, and Candida albicans. In vivo, EECM alleviated the clinical signs of colitis, reduced histological damage, and modulated hematological and biochemical parameters. Overall, EECM exhibited significant antioxidant and anti-inflammatory activities and may represent a promising natural candidate for IBD management. Further investigations into chronic experimental models are necessary to establish their therapeutic relevance.
- 22 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11299
Open AccessEthanolic Extract of Kinkeliba (Combretum micranthum), Rich in Phenolic Compounds Mitigates DSS-Induced Ulcerative Colitis in C57BL/6 Mice via Antioxidation and Microbiota Regulation
Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract, and current therapies are limited by adverse side effects. Combretum micranthum G. Don (kinkeliba), a medicinal plant traditionally used in West Africa, has been reported to possess pharmacological activities and a favorable safety profile. In this study, an ethanolic extract of Combretum micranthum (EECM) was characterized using HPLC-DAD-ESI-MS to identify its phenolic constituents. Acute colitis was induced in C57BL/6 mice using 3% DSS, while EECM (100 and 200 mg/kg) was administered orally for seven days. Disease Activity Index was monitored daily, and colonic injuries were evaluated through macroscopic and histological analyses, as well as hematological and biochemical assessments. In vitro, EECM contained 293.54 mg/g of total phenolic compounds and showed strong antioxidant activity in DPPH, ABTS, and FRAP assays. Furthermore, the extract exhibited antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Salmonella enterica, and Streptococcus pyogenes at various concentrations. In contrast, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa were not affected at the tested concentrations. No antifungal activity was detected against the filamentous fungus Aspergillus brasiliensis and the yeasts Saccharomyces cerevisiae, Candida parapsilosis, and Candida albicans. In vivo, EECM alleviated the clinical signs of colitis, reduced histological damage, and modulated hematological and biochemical parameters. Overall, EECM exhibited significant antioxidant and anti-inflammatory activities and may represent a promising natural candidate for IBD management. Further investigations into chronic experimental models are necessary to establish their therapeutic relevance.
- Open Access
Acute and Subacute Oral Toxicity Assessment of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in BALB/c Mice
Combretum micranthum G. Don (kinkeliba) is a medicinal plant traditionally employed in West Africa for its diuretic and gastrointestinal therapeutic properties. Despite its extensive ethnomedicinal use, comprehensive toxicological assessments are still lacking. This study aimed to characterize the phenolic composition of C. micranthum ethanolic leaf extract using HPLC-DAD-ESI-MS and evaluate its acute and subacute oral toxicity in BALB/c mice, per OECD Guideline 420. Female mice received oral doses of 50, 300, and 2000 mg/kg of extract for acute toxicity assessment for 14 days. In the subacute study, both sexes were administered daily doses at the same concentrations over 28 days. Clinical signs, body weight, and food and water consumption were regularly monitored throughout both protocols. At the end of each study, hematological, biochemical, and histopathological parameters were analyzed. Phenolic profiling revealed nine major compounds with a total of 293.54 mg/g extract. No mortality or significant clinical manifestations were observed at any dose. However, significant variations in platelet counts and amylase activity were noted in the acute phase. In the subacute model, slight, non-critical alterations in hepatic and renal biomarkers were observed, without signs of systemic toxicity. Histopathological examination revealed similar lesions in both acute and subacute phases, including multifocal inflammatory infiltrates (lymphocytes and neutrophils) in the periportal area of the liver, minimal bacterial overgrowth in the superficial layer of the gastric mucosa, minimal medullary mineralization and inflammatory infiltrates with lymphocytes in the kidneys, and minimal to moderate vacuolization in the pancreatic acini. These results indicate that C. micranthum ethanolic extract is relatively safe at the tested doses, reinforcing its traditional use and supporting further research into its pharmacological potential.
Open AccessAcute and Subacute Oral Toxicity Assessment of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in BALB/c Mice
Combretum micranthum G. Don (kinkeliba) is a medicinal plant traditionally employed in West Africa for its diuretic and gastrointestinal therapeutic properties. Despite its extensive ethnomedicinal use, comprehensive toxicological assessments are still lacking. This study aimed to characterize the phenolic composition of C. micranthum ethanolic leaf extract using HPLC-DAD-ESI-MS and evaluate its acute and subacute oral toxicity in BALB/c mice, per OECD Guideline 420. Female mice received oral doses of 50, 300, and 2000 mg/kg of extract for acute toxicity assessment for 14 days. In the subacute study, both sexes were administered daily doses at the same concentrations over 28 days. Clinical signs, body weight, and food and water consumption were regularly monitored throughout both protocols. At the end of each study, hematological, biochemical, and histopathological parameters were analyzed. Phenolic profiling revealed nine major compounds with a total of 293.54 mg/g extract. No mortality or significant clinical manifestations were observed at any dose. However, significant variations in platelet counts and amylase activity were noted in the acute phase. In the subacute model, slight, non-critical alterations in hepatic and renal biomarkers were observed, without signs of systemic toxicity. Histopathological examination revealed similar lesions in both acute and subacute phases, including multifocal inflammatory infiltrates (lymphocytes and neutrophils) in the periportal area of the liver, minimal bacterial overgrowth in the superficial layer of the gastric mucosa, minimal medullary mineralization and inflammatory infiltrates with lymphocytes in the kidneys, and minimal to moderate vacuolization in the pancreatic acini. These results indicate that C. micranthum ethanolic extract is relatively safe at the tested doses, reinforcing its traditional use and supporting further research into its pharmacological potential.
- Open Access
- 16 May 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (5) , 485
Veterinary Perspectives on Hemoglobin-Based Oxygen Carriers in Experimental Hemorrhagic Shock: Insights from Rabbit Models
Hemoglobin-based oxygen carriers (HBOCs) represent a promising alternative to traditional blood transfusions, offering the advantages of extended shelf life and avoiding blood compatibility limitations and infection risks. Positive effects of hemoglobin-based oxygen carriers (HBOCs) on hemorrhagic shock have been researched across various animal species, including swine, rats, rabbits, guinea pigs, and dogs. As previously described, HBOCs based on ovine hemoglobin display better efficiency in the context of hemorrhagic shock compared to those based on the more commonly used bovine hemoglobin. This was evidenced through higher survival rates and more favorable histopathological and immunological outcomes. The vascular effects of ovine hemoglobin polymerized with glutaraldehyde exposure included the absence of hypertension, minimal endothelial damage with slight alterations in inducible nitric oxide synthase (iNOS), and reduced vascular inflammation mediated by interleukin-10 (IL-10). Ovine hemoglobin has emerged as a particularly promising raw material for the development of HBOCs, surpassing bovine and human hemoglobin due to its advantages in availability and efficacy. Furthermore, reducing oxidative stress by polymerizing hemoglobin with glutaraldehyde is most effective with ovine hemoglobin compared to bovine hemoglobin. This study evaluates the effectiveness of ovine hemoglobin polymerized with glutaraldehyde in managing hemorrhagic shock in rabbits, with a focus on its ability to maintain blood pressure, support oxygen transport, and assess potential systemic and oxidative responses. Fifteen adult New Zealand white rabbits, divided into three equal groups, were included in this study: a negative control group transfused with colloid solutions, a positive control group treated with autotransfusion, and a group receiving HBOCs. All groups underwent a hemorrhagic shock protocol, with 40% of their total blood volume withdrawn under deep anesthesia, followed by transfusions 30 min later. Vital parameters, including invasive arterial blood pressure, heart rate, and end-tidal CO2, were measured throughout the experimental procedures. Arterial blood gas samples were collected before the procedures, after hemorrhagic shock induction, and at the conclusion of the transfusion. In summary, HBOCs offer a promising solution for oxygen delivery, but their effects on blood chemistry, particularly CO2 and lactate levels, must be considered. Although no direct oxygenation issues were observed in experimental models, elevated CO2 levels and the interference of HBOCs with lactate measurements emphasize the importance of vigilant clinical monitoring. Polymerized hemoglobin provides a non-nephrotoxic alternative, but challenges persist in preventing nitric oxide scavenging and ensuring effective oxygen delivery.
- 16 May 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (5) , 485
Open AccessVeterinary Perspectives on Hemoglobin-Based Oxygen Carriers in Experimental Hemorrhagic Shock: Insights from Rabbit Models
Hemoglobin-based oxygen carriers (HBOCs) represent a promising alternative to traditional blood transfusions, offering the advantages of extended shelf life and avoiding blood compatibility limitations and infection risks. Positive effects of hemoglobin-based oxygen carriers (HBOCs) on hemorrhagic shock have been researched across various animal species, including swine, rats, rabbits, guinea pigs, and dogs. As previously described, HBOCs based on ovine hemoglobin display better efficiency in the context of hemorrhagic shock compared to those based on the more commonly used bovine hemoglobin. This was evidenced through higher survival rates and more favorable histopathological and immunological outcomes. The vascular effects of ovine hemoglobin polymerized with glutaraldehyde exposure included the absence of hypertension, minimal endothelial damage with slight alterations in inducible nitric oxide synthase (iNOS), and reduced vascular inflammation mediated by interleukin-10 (IL-10). Ovine hemoglobin has emerged as a particularly promising raw material for the development of HBOCs, surpassing bovine and human hemoglobin due to its advantages in availability and efficacy. Furthermore, reducing oxidative stress by polymerizing hemoglobin with glutaraldehyde is most effective with ovine hemoglobin compared to bovine hemoglobin. This study evaluates the effectiveness of ovine hemoglobin polymerized with glutaraldehyde in managing hemorrhagic shock in rabbits, with a focus on its ability to maintain blood pressure, support oxygen transport, and assess potential systemic and oxidative responses. Fifteen adult New Zealand white rabbits, divided into three equal groups, were included in this study: a negative control group transfused with colloid solutions, a positive control group treated with autotransfusion, and a group receiving HBOCs. All groups underwent a hemorrhagic shock protocol, with 40% of their total blood volume withdrawn under deep anesthesia, followed by transfusions 30 min later. Vital parameters, including invasive arterial blood pressure, heart rate, and end-tidal CO2, were measured throughout the experimental procedures. Arterial blood gas samples were collected before the procedures, after hemorrhagic shock induction, and at the conclusion of the transfusion. In summary, HBOCs offer a promising solution for oxygen delivery, but their effects on blood chemistry, particularly CO2 and lactate levels, must be considered. Although no direct oxygenation issues were observed in experimental models, elevated CO2 levels and the interference of HBOCs with lactate measurements emphasize the importance of vigilant clinical monitoring. Polymerized hemoglobin provides a non-nephrotoxic alternative, but challenges persist in preventing nitric oxide scavenging and ensuring effective oxygen delivery.
- Open Access
- 1 January 2025
- Published by Wiley in Veterinary Medicine International
- Vol. 2025 (1)
Anesthetic Protocols for Enhancing Physiological Stability in Rabbits During Hemorrhagic Shock
Study Background: Rabbits are commonly used in experimental research; however, their sensitivity to handling‐induced stress and cardiovascular instability poses considerable challenges. These complications are not fully prevented by standard preanesthetic medication, making them less reliable, particularly in studies involving hemorrhagic shock. Aim: The aim of this study was to identify enhanced anesthetic protocols that effectively maintain physiological stability and prevent respiratory or cardiac failure during the induction of hemorrhagic shock. Methods: Fifteen adult female New Zealand White rabbits were divided into three equal groups: one received dexmedetomidine and ketamine; the other received the same induction followed by isoflurane maintenance; while the third, in addition to the medication of the second group, received a constant rate ketamine infusion. Vital parameters such as heart rate, blood pressure, oxygen saturation, end‐tidal CO 2 , reflexes, and core body temperature were continuously monitored. Hemorrhagic shock was induced by withdrawing 40% of the total blood volume through a surgically cannulated carotid artery. Results: Among the three, the third protocol provided the most consistent anesthesia depth in conjunction with stable vital signs, ensuring animal safety and effective modeling of hemorrhagic shock. Conclusions: These results support the use of a combined inhalant anesthetic with continuous ketamine infusion to enhance physiological stability in rabbits during complex procedures, ultimately improving both the reliability of experimental data and animal welfare.
- 1 January 2025
- Published by Wiley in Veterinary Medicine International
- Vol. 2025 (1)
Open AccessAnesthetic Protocols for Enhancing Physiological Stability in Rabbits During Hemorrhagic Shock
Study Background: Rabbits are commonly used in experimental research; however, their sensitivity to handling‐induced stress and cardiovascular instability poses considerable challenges. These complications are not fully prevented by standard preanesthetic medication, making them less reliable, particularly in studies involving hemorrhagic shock. Aim: The aim of this study was to identify enhanced anesthetic protocols that effectively maintain physiological stability and prevent respiratory or cardiac failure during the induction of hemorrhagic shock. Methods: Fifteen adult female New Zealand White rabbits were divided into three equal groups: one received dexmedetomidine and ketamine; the other received the same induction followed by isoflurane maintenance; while the third, in addition to the medication of the second group, received a constant rate ketamine infusion. Vital parameters such as heart rate, blood pressure, oxygen saturation, end‐tidal CO 2 , reflexes, and core body temperature were continuously monitored. Hemorrhagic shock was induced by withdrawing 40% of the total blood volume through a surgically cannulated carotid artery. Results: Among the three, the third protocol provided the most consistent anesthesia depth in conjunction with stable vital signs, ensuring animal safety and effective modeling of hemorrhagic shock. Conclusions: These results support the use of a combined inhalant anesthetic with continuous ketamine infusion to enhance physiological stability in rabbits during complex procedures, ultimately improving both the reliability of experimental data and animal welfare.